HealthcareRezolute rises as FDA lifts clinical hold on hyperinsulinism therapyBy Helitra.com·September 10, 2024·1 min read Rezolute rises as FDA lifts clinical hold on hyperinsulinism therapy Source: SeekingalphaADVERTISEMENT ADVERTISEMENTClinical FDA hold hyperinsulinism lifts Rezolute rises therapy Post navigation Previous storyEvaxion reports positive mid-stage trial data on lead cancer vaccine candidate EVX-01Next storyAutonomix rises after it reports reduction of pain in pancreatic cancer treatment
Fitness · HealthcareWeights Versus Cardio: Which Exercise Is Actually Better for Your Mental Health?November 22, 2026A major new study suggests lifting weights could do more than build muscle. It may also help reduce symptoms of depression—and researchers found…
Fitness · HealthcareNew endometriosis study finds 27 fresh clues about the painful disease affecting 1 in 10 womenNovember 22, 2026The Brief A large international study of over 1 million people from diverse racial backgrounds identified 58 DNA segments linked to endometriosis, including…
Fitness · HealthcareResearchers Found That Doing This Is Just as Effective as the Gym for Older AdultsNovember 22, 2026Feeling exhausted after a few household chores might seem like an unavoidable part of getting older. But new research from the University of…